Compare IVDA & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVDA | XXII |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 7.8M |
| IPO Year | N/A | N/A |
| Metric | IVDA | XXII |
|---|---|---|
| Price | $1.04 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.2M | 187.9K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,395,926.00 | ★ $20,346,000.00 |
| Revenue This Year | $340.48 | N/A |
| Revenue Next Year | N/A | $136.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.56 | 16.98 |
| 52 Week Low | $0.61 | $0.78 |
| 52 Week High | $8.05 | $287.27 |
| Indicator | IVDA | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 44.96 |
| Support Level | $1.11 | $1.06 |
| Resistance Level | $1.37 | $1.17 |
| Average True Range (ATR) | 0.16 | 0.08 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 33.15 | 67.12 |
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.